StemCyte has officially announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long...
Fullpower Technologies, in collaboration with Stanford Sleep Medicine and UCSF Department of Psychiatry and Behavioral Sciences, has officially presented two new studies at the...
Research Solutions, a trusted provider of cloud-based workflow solutions to accelerate research for R&D-driven organizations, has officially announced the launch of a new Clinical...
The US Food and Drug Administration has officially approved Vertex Pharmaceuticals Incorporated’s therapeutic ALYFTREK.
According to certain reports, the stated drug happens to be a...
